During the past decade, Oklahoma Heart Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 31 clinical trials were completed, i.e. on average, 147.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oklahoma Heart Hospital" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "Edwards Lifesciences" with 4 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oklahoma Heart Hospital" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "American College of Cardiology" with 1 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Oklahoma Heart Hospital" are "Heart Failure" (12 trials), "Coronary Artery Disease" (11 trials), "Mitral Regurgitation" (4 trials), "Coronary Disease" (3 trials) and "Mitral Valve Insufficiency" (3 trials). Many other conditions were trialed in "Oklahoma Heart Hospital" in a lesser frequency.

Most popular intervention types in "Oklahoma Heart Hospital" are "Device" (42 trials), "Drug" (18 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bardoxolone methyl" (2 trials), "HeartPOD™ System" (2 trials), "PF-04950615 (RN316)" (2 trials) and "3 months of dual antiplatelet therapy (DAPT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oklahoma Heart Hospital" are 58 trials for "All" genders.

Currently, there are NaN active trials in "Oklahoma Heart Hospital". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Oklahoma Heart Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Oklahoma Heart Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 26 trials that are defined as “Not Applicable".

Oklahoma Heart Hospital has several departments that took part in Clinical trials: "Oklahoma Foundation for Cardiovascular Research" - 97 trials, "Oklahoma Heart Hospital Physicians" - 6 trials, "Oklahoma Heart Hospital South" - 4 trials